Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Rodig

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
Annual Review of Pathology|May 20, 2016
The Role of Surgical Pathology in Guiding Cancer ImmunotherapyScott B Lovitch, Scott J Rodig
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Overview of Tissue Imaging MethodsSanjay S Patel, Scott J Rodig
Frontiers in Immunology|February 10, 2022
Editorial: Defining the Spatial Organization of Immune Responses to Cancer and Viruses <i>In Situ</i>Darci Phillips, Scott J Rodig, Sizun Jiang
The American Journal of Surgical Pathology|May 6, 2010
Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocationMarianna B Ruzinova, Tyler Caron, Scott J Rodig
Archives of Pathology & Laboratory Medicine|December 23, 2011
Emerging targeted therapies for lymphoid malignanciesOlga Pozdnyakova, Jeffery L Kutok, Scott J Rodig
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Reply to Z. Wu et alDonna S Neuberg, Scott J Rodig, Margaret A Shipp
Human Pathology|January 7, 2003
CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomasScott J Rodig, Dan Jones, Aliakbar Shahsafaei, et al.
Human Pathology|February 16, 2005
The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disordersScott J Rodig, Aliakbar Shahsafaei, Betty Li, et al.
The American Journal of Surgical Pathology|December 29, 2007
Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocationScott J Rodig, Jo-Anne Vergilio, Aliakbar Shahsafaei, et al.
European Journal of Cancer (Oxford, England : 1990)|April 27, 2010
The biology and treatment of EML4-ALK non-small cell lung cancerTakaaki Sasaki, Scott J Rodig, Lucian R Chirieac, et al.
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
Annual Review of Pathology|May 20, 2016
The Role of Surgical Pathology in Guiding Cancer ImmunotherapyScott B Lovitch, Scott J Rodig
Methods in Molecular Biology (Clifton, N.J.)|September 11, 2019
Overview of Tissue Imaging MethodsSanjay S Patel, Scott J Rodig
Frontiers in Immunology|February 10, 2022
Editorial: Defining the Spatial Organization of Immune Responses to Cancer and Viruses <i>In Situ</i>Darci Phillips, Scott J Rodig, Sizun Jiang
The American Journal of Surgical Pathology|May 6, 2010
Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocationMarianna B Ruzinova, Tyler Caron, Scott J Rodig
Archives of Pathology & Laboratory Medicine|December 23, 2011
Emerging targeted therapies for lymphoid malignanciesOlga Pozdnyakova, Jeffery L Kutok, Scott J Rodig
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Reply to Z. Wu et alDonna S Neuberg, Scott J Rodig, Margaret A Shipp
Human Pathology|January 7, 2003
CCR6 is a functional chemokine receptor that serves to identify select B-cell non-Hodgkin's lymphomasScott J Rodig, Dan Jones, Aliakbar Shahsafaei, et al.
Human Pathology|February 16, 2005
The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disordersScott J Rodig, Aliakbar Shahsafaei, Betty Li, et al.
The American Journal of Surgical Pathology|December 29, 2007
Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocationScott J Rodig, Jo-Anne Vergilio, Aliakbar Shahsafaei, et al.
European Journal of Cancer (Oxford, England : 1990)|April 27, 2010
The biology and treatment of EML4-ALK non-small cell lung cancerTakaaki Sasaki, Scott J Rodig, Lucian R Chirieac, et al.
Pageof 30